Browsing Breast Cancer Research by author "Battisti, Nicolo"
Now showing items 21-24 of 24
-
Systemic therapy for early breast cancer in older adults: current status and prospects.
Battisti, NML; Biganzoli, L (LIPPINCOTT WILLIAMS & WILKINS, 2021-11-01)PURPOSE OF REVIEW: In this review, we describe the evidence on the efficacy and the safety of systemic treatments for the management of early breast cancer (EBC) in older individuals. RECENT FINDINGS: Chemotherapy has a ... -
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper.
Battisti, NML; Liposits, G; De Glas, NA; Gomes, F; Baldini, C; et al. (SPRINGER, 2020-07-28)PURPOSE OF REVIEW: Decision-making for systemic treatments in older patients with cancer is difficult because of concerns for decreased organ function, risk of toxicity, limited life expectancy due to comorbidities and the ... -
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).
Biganzoli, L; Battisti, NML; Wildiers, H; McCartney, A; Colloca, G; et al. (ELSEVIER SCIENCE INC, 2021-07-01)Breast cancer is increasingly prevalent in older adults and is a substantial part of routine oncology practice. However, management of breast cancer in this population is challenging because the disease is highly heterogeneous ... -
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper.
Battisti, NML; De Glas, N; Sedrak, MS; Loh, KP; Liposits, G; et al. (SAGE PUBLICATIONS LTD, 2018-11-20)The current standard of care for the management of estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer has been redefined by the introduction of cyclin-dependent kinase ...